Lv1
18 积分 2025-10-22 加入
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
19天前
已完结
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report
1个月前
已完结
Expert consensus on interstitial lung disease associated with systemic autoimmune diseases. Executive summary
1个月前
已完结
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis
2个月前
已完结
A Novel Tool for Predicting Malignant Disease in Adult Patients With Dermatomyositis
7个月前
已完结
Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of Hope
9个月前
已完结
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
11个月前
已完结
Vascular endothelial growth factor and its receptors
11个月前
已完结
Vascular endothelial growth factor (VEGF) and its receptors
11个月前
已完结
皖公网安备34019202002308
